Scientists advance type 1 diabetes treatment with cutting-edge stem cell and gene editing technologies

Researchers review significant advancements and ongoing challenges in cell replacement therapies for type 1 diabetes, highlighting innovative approaches in stem cell-derived islets and immune protection strategies.

Optimizing antithrombotic treatment for individualized cardiovascular care

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Thrombosis, the process of blood clot formation in blood vessels, is an important protective

March 12, 2024

Novo Nordisk’s longstanding GLP-1 reduced BMI by 7% in children in Phase 3 trial

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 12, 2024

Twin Health Unveils Digital Twin AI for Weight Loss with GLP-1 Elimination

What You Should Know: – Today, Twin Health announced it is extending its whole body digital twin AI platform, proven to help members achieve remission of type 2 diabetes

May 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.